Todd Watanabe
Algemeen Directeur bij ARCUTIS BIOTHERAPEUTICS, INC.
Vermogen: 9 M $ op 30-04-2024
Profiel
Todd Franklin Watanabe was the founder of Kanan Therapeutics, Inc. (founded in 2015) where he held the title of Chief Operating Officer from 2015 to 2018.
He is currently the President, Chief Executive Officer & Director at Arcutis Biotherapeutics, Inc. (since 2016) and a Director at Amunix Pharmaceuticals, Inc. (since 2021).
Previously, he worked as the VP-Strategy & Corporate Development at Kythera Biopharmaceuticals LLC from 2013 to 2015.
Mr. Watanabe's education includes undergraduate and graduate degrees from Georgetown University.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 02-05-2024 | 1 091 890 ( 0.95% ) | 9 M $ | 30-04-2024 |
Actieve functies van Todd Watanabe
| Bedrijven | Functie | Begin |
|---|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Algemeen Directeur | 01-04-2017 |
Amunix Pharmaceuticals, Inc.
 Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Directeur/Bestuurslid | 23-06-2021 |
Eerdere bekende functies van Todd Watanabe
| Bedrijven | Functie | Einde |
|---|---|---|
| Kanan Therapeutics, Inc. | Oprichter | 01-02-2018 |
| KYTHERA BIOPHARMACEUTICALS INC | Corporate Officer/Principal | 01-11-2015 |
Opleiding van Todd Watanabe
| Georgetown University | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| ARCUTIS BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
Kythera Biopharmaceuticals LLC
 Kythera Biopharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Kythera Biopharmaceuticals LLC operates as a clinical-stage biopharmaceutical company. It focuses on the discovery, development, and commercialization of novel prescription products for the aesthetic medicine market. The company was founded by Jay Edward Birnbaum, Amit D. Munshi, Nathaniel Eames David, and Keith R. Leonard, Jr. on June 3, 2004 and is headquartered in Westlake, CA. | Health Technology |
| Kanan Therapeutics, Inc. | |
Amunix Pharmaceuticals, Inc.
Amunix Pharmaceuticals, Inc. BiotechnologyHealth Technology Amunix Pharmaceuticals, Inc. manufactures and fabricates drugs. The firm’s pipeline products are based on proprietary XTEN half-life extension, Antibody-XTEN-Drug Conjugate, ProTIA pro-drug and bispecific T-cell engager platform technologies. The company was founded by Willem P.C. Stemmer and Volker Schellenberger in 2006 and is headquartered in Mountain View, CA. | Health Technology |